Simulations Plus, Inc. Plans Quarterly Dividend of $0.06 (NASDAQ:SLP)

Simulations Plus, Inc. (NASDAQ:SLP) announced a quarterly dividend on Wednesday, April 3rd, Zacks reports. Investors of record on Monday, April 29th will be paid a dividend of 0.06 per share by the technology company on Monday, May 6th. This represents a $0.24 annualized dividend and a dividend yield of 0.51%. The ex-dividend date of this dividend is Friday, April 26th.

Simulations Plus has a dividend payout ratio of 29.6% meaning its dividend is sufficiently covered by earnings.

Simulations Plus Trading Up 1.4 %

Shares of SLP opened at $46.65 on Thursday. The stock’s 50-day moving average price is $43.52 and its two-hundred day moving average price is $40.95. Simulations Plus has a 12 month low of $32.69 and a 12 month high of $52.69. The company has a market capitalization of $932.53 million, a PE ratio of 88.02 and a beta of 0.72.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Wednesday, April 3rd. The technology company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.02. The company had revenue of $18.31 million for the quarter, compared to analyst estimates of $17.31 million. Simulations Plus had a return on equity of 7.95% and a net margin of 16.22%. The firm’s quarterly revenue was up 16.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.20 earnings per share. Equities research analysts predict that Simulations Plus will post 0.67 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Craig Hallum boosted their target price on shares of Simulations Plus from $50.00 to $51.00 and gave the company a “buy” rating in a report on Thursday, January 4th.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $39.94, for a total value of $798,800.00. Following the transaction, the director now directly owns 3,600,195 shares of the company’s stock, valued at $143,791,788.30. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Simulations Plus news, Director Walter S. Woltosz sold 18,945 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $38.02, for a total value of $720,288.90. Following the completion of the sale, the director now directly owns 3,641,250 shares of the company’s stock, valued at $138,440,325. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $39.94, for a total value of $798,800.00. Following the transaction, the director now directly owns 3,600,195 shares in the company, valued at approximately $143,791,788.30. The disclosure for this sale can be found here. 20.90% of the stock is currently owned by insiders.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.